Capha Pharmaceuticals Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported net loss was CAD 0.02221 million compared to CAD 0.011796 million a year ago.
For the six months, net loss was CAD 0.037254 million compared to CAD 0.024064 million a year ago.